New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 12, 2013
06:04 EDTGSK, SSNLF, PFE, AAPL, MSFTOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: With the realization that Microsoft’s (MSFT) new Windows 8 software will not reignite computer sales, attention is shifting to the company's next big effort to regain relevance: Windows Blue, the software project which has yet to formally defined, the Wall Street Journal reports...Of the hundreds of millions of dollars paid each year to compensate physicians for pharmaceutical marketing and research efforts, Pfizer (PFE) and GlaxoSmithKline (GSK) are cutting back. In addition, layoffs of pharmaceutical-sales representatives and patent expirations for big-selling drugs have resulted in fewer sales calls on doctors, the Wall Street Journal reports...REUTERS: World shares declined today as investors locked in profits at the end of what was set to be the second best week of the year for stocks, while the dollar held near a four-year high against the yen, Reuters reports...No fewer than three Wall Street analysts this week wrote reports about the possibility of the biggest banks breaking themselves up to increase profitability, signaling that investors may be more willing to embrace an idea that is still toxic to some lawmakers in Washington, Reuters reports..BLOOMBERG: Apple (AAPL) and Samsung (SSNLF) are being beaten on price in the fast-growing Indian smartphone market by a couple of aggressive local competitors, fueled by Indians buying their first smartphone to surf the Internet, which will be accessed by more than 300M people by 2017, Bloomberg reports...Gold swung between gains and declines as it headed for a third weekly drop in London on speculation a strengthening U.S. economy will curb demand for a protection of wealth. Prices are down 7% this year on rising optimism that the U.S. will help lead a global economic recovery, Bloomberg reports.
News For MSFT;PFE;GSK;AAPL;SSNLF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
January 13, 2015
07:36 EDTAAPLApple survey suggests demand remains strong, says Canaccord
Subscribe for More Information
07:18 EDTAAPLQuanta ramps up production of 12-inch MacBook Air, DigiTimes reports
Subscribe for More Information
06:21 EDTAAPLApple upgraded at Credit Suisse
As previously reported, Credit Suisse upgraded Apple to Outperform from Neutral. The firm raised iPhone volume estimates again to 215M units for both FY15/16 and sees $10 EPS power in CY16 based on a solid and sustainable iPhone trends combined with a muted response from Samsung. Additionally, the firm believes excessive net cash levels indicate a new $200B return program should occur. Price target raised to $130 from $110.
06:20 EDTAAPLApple supplier shows 'unbreakable' smartphone with sapphire display, WSJ says
Subscribe for More Information
06:18 EDTAAPLSilicon Valley shuttle drivers looking to unionize, USA Today reports
Subscribe for More Information
06:09 EDTAAPLApple implied volatility of 38 at upper end of index mean range
Subscribe for More Information
06:06 EDTAAPLApple upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
January 12, 2015
16:50 EDTAAPLGartner says worldwide PC shipments in Q4 grew 1%
Subscribe for More Information
16:00 EDTAAPLOptions Update; January 12, 2015
iPath S&P 500 VIX Short-Term Futures up 1.57 to 33.54. Option volume leaders: AAPL TSLA TWTR AMZN AA SIRI RIG FRO C according to Track Data.
12:53 EDTAAPLApple falls, levels to watch
Subscribe for More Information
12:45 EDTPFEActavis CEO says 'can't speculate on what Pfizer is going to do'
Subscribe for More Information
12:04 EDTGSKNovartis sees closing GSK transactions in 1H15
Novartis (NVS) says portfolio transformation is progressing "on track." Sees closing GlaxoSmithKline (GSK) transactions in 1H. In 2015, plans to execute integration of GSK oncology business, execute separation of Vaccines, ensure successful start-up of Consumer Health JV with GSK. Sees NBS to continue to deliver synergies. Comments from slides that are being presented at the JP Morgan Healthcare Conference.
09:34 EDTAAPLActive equity options trading
Subscribe for More Information
09:22 EDTPFE23andMe announces collaboration with Pfizer
Google (GOOG)-backed 23andMe announced an agreement with Pfizer (PFE) that will provide Pfizer with access to 23andMe’s research platform, including services and Research Portal analysis of 23andMe’s genotyped population of over 800,000 individuals, of which more than 80 percent have consented to participate in research. 23andMe’s Research Portal enables qualified and approved scientists outside of 23andMe the opportunity to leverage the company’s unique research model while still protecting the privacy and security of 23andMe’s customers. As a part of the agreement, the companies will collaborate on certain genome-wide association studies, surveys, and clinical trial recruitment. One of these collaborations will be a longitudinal study to better understand the genetics of lupus. This study will entail enrollment and genotyping of 5,000 people into a new lupus research community, and include the integration of medical records, targeted bio-sampling along with genetic information for all participants. This announcement follows a collaboration between 23andMe and Pfizer to enroll 10,000 people with Inflammatory Bowel Disease in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Nearly 4,000 patients have been enrolled in the community since August 2014.
08:37 EDTGSK, PFEShire deal suggests most biotech companies in play, says JMP Securities
After Shire (SHPG) agreed to buy NPS Pharmaceuticals (NPSP), JMP Securities says the deal indicates that most biotech companies are in play, particularly those with worldwide rights to their products for well-defined patient populations. The firm expects investors to speculate all week about potential new targets in the space. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
08:21 EDTAAPLApple poised to gain market share, says JMP Securities
Subscribe for More Information
08:05 EDTMSFTGameStop to use Microsoft Azure to stream game content, promotional materials
Subscribe for More Information
06:34 EDTSSNLFSamsung expected to launch two versions of Galaxy S6 phone in March, BI reports
Samsung will launch two versions of its Galaxy S6 phone in March at the Mobile World Congress, Business Insider reports, citing sources. One version will be made with metal, a departure from the plastic casings used in most Galaxy phones, while the other will have a curved screen, the sources say. Reference Link
06:22 EDTGSKWHO approves 2 ebola vaccines to enter West Africa trials, Financial Times says
Subscribe for More Information
06:11 EDTSSNLFSamsung, Pattern Energy complete wind energy project in Ontario
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use